arrow
L

Lisa Licitra

Fondazione IRCCS Istituto Nazionale dei Tumori
H指数:86
被引数:4.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Liquid biopsies for BRAF V600E assessment and monitoring in anaplastic thyroid carcinoma: a real-world study of a tertiary cancer center

液态活检用于评估和监测间变性甲状腺癌中的BRAF V600E:一项三级癌症中心的真实世界研究

2026-06-230
OAAI
Fragmenting the future with FLARE: a comprehensive fragmentomics pipeline based on long-read nanopore sequencing

利用FLARE进行未来碎片化:一种基于长读长纳米孔测序的全面碎片组学分析流程

2026-03-130
OAAI
Corrigendum to “Epithelial head and neck cancer survival in Europe: Geographical variation, time trends and long term survival” Eur J Cancer 229 (October) (2025) 115692

勘误:“Epithelial head and neck cancer survival in Europe: Geographical variation, time trends and long term survival” Eur J Cancer 229 (October) (2025) 115692

2025-11-290
PRE
Validation of a prognostic nomogram for locally advanced oropharyngeal carcinoma treated with intensity-modulated radiotherapy with/without systemic therapy

验证接受调强放射治疗联合/不联合全身治疗的局部晚期口咽癌患者的预后列线图

2025-10-270
OAAI
Health-related quality of life outcomes from KEYNOTE-412: chemoradiotherapy with or without pembrolizumab in participants with head and neck squamous cell carcinoma

健康相关生活质量结局:来自KEYNOTE-412的研究——头颈鳞状细胞癌患者接受含或不含有pembrolizumab的化疗与放疗联合治疗的结果

2025-10-060
OAAI
Lenvatinib in advanced thyroid, salivary gland, endometrial, and hepatocellular carcinomas: a real-world study on treatment duration and toxicity management

伦伐替尼在晚期甲状腺癌、唾液腺癌、子宫内膜癌和肝细胞癌中的应用:一项关于治疗持续时间与毒性管理的真实世界研究

2025-09-120
OA
A multicenter retrospective analysis of recurrent/metastatic nasopharyngeal cancer from non-endemic areas: results in the pre-immunotherapy era

非流行区复发性/转移性鼻咽癌的多中心回顾性分析:免疫治疗时代前的结果

2025-09-020
PRE
Systemic anticancer therapy during end of life in head and neck squamous cell carcinoma patients. A retrospective single center study.

头颈部鳞状细胞癌患者临终期系统性抗肿瘤治疗。一项回顾性单中心研究。

2025-08-290
OAAI
Longitudinal assessment of plasma EBV-DNA in non-endemic EBV-related nasopharyngeal cancer (NPC): the LEA study

非流行区EBV相关鼻咽癌(NPC)血浆EBV-DNA的纵向评估:LEA研究

2025-07-090
PRE
Development, Validation, and Valuation of a Head and Neck Cancer-Specific Health Utility Instrument (HNC-8D) A Head and Neck Cancer International Group Collaborative Study

头颈癌特异性健康效用量表(HNC-8D)的开发、验证与价值评估:一项头颈癌国际协作组合作研究

2025-06-010
PRE
A phase II study of monalizumab and durvalumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: results of the I2 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)

一项关于monalizumab和durvalumab在复发性/转移性头颈鳞状细胞癌患者中的II期研究:EORTC-HNCG-1559试验(UPSTREAM)中I2组的成果

2025-05-010
OAAI